Plasma triacylglycerols are biomarkers of β-cell function in mice and humans

[1]  L. Groop,et al.  Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY Study , 2021, Diabetes.

[2]  E. Bonifacio,et al.  Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes , 2021, Nature Metabolism.

[3]  A. Feuchtinger,et al.  Inceptor counteracts insulin signalling in β-cells to control glycaemia , 2021, Nature.

[4]  U. Boggi,et al.  Persistent or Transient Human β Cell Dysfunction Induced by Metabolic Stress: Specific Signatures and Shared Gene Expression with Type 2 Diabetes. , 2020, Cell reports.

[5]  A. Sheikhi,et al.  Efficacy of l-carnitine supplementation for management of blood lipids: A systematic review and dose-response meta-analysis of randomized controlled trials. , 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[6]  B. Thorens,et al.  Use of preclinical models to identify markers of type 2 diabetes susceptibility and novel regulators of insulin secretion – A step towards precision medicine , 2019, Molecular metabolism.

[7]  M. Waugh.  The Great Escape: how phosphatidylinositol 4-kinases and PI4P promote vesicle exit from the Golgi (and drive cancer). , 2019, The Biochemical journal.

[8]  P. Meikle,et al.  Lipidomic profiling reveals early-stage metabolic dysfunction in overweight or obese humans. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[9]  P. Thorsby,et al.  Vitamin D Increases Glucose Stimulated Insulin Secretion from Insulin Producing Beta Cells (INS1E) , 2019, International journal of endocrinology and metabolism.

[10]  Si Yang,et al.  Identification of key gene pathways and coexpression networks of islets in human type 2 diabetes , 2018, Diabetes, metabolic syndrome and obesity : targets and therapy.

[11]  E. Bonifacio,et al.  Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes , 2017, Diabetologia.

[12]  C. Gieger,et al.  Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study , 2017, Diabetologia.

[13]  Raquel S. Sevilla,et al.  Exome-wide association study of plasma lipids in >300,000 individuals , 2017, Nature Genetics.

[14]  Ioannis Xenarios,et al.  Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans. , 2017, Cell reports.

[15]  I. Xenarios,et al.  Molecular phenotyping of multiple mouse strains under metabolic challenge uncovers a role for Elovl2 in glucose-induced insulin secretion , 2017, Molecular metabolism.

[16]  Nicholas J Wareham,et al.  A Systematic Review of Biomarkers and Risk of Incident Type 2 Diabetes: An Overview of Epidemiological, Prediction and Aetiological Research Literature , 2016, PloS one.

[17]  S. Tavazoie,et al.  PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion. , 2016, Cancer cell.

[18]  M. A. Surma,et al.  An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids , 2015, European journal of lipid science and technology : EJLST.

[19]  Marja-Riitta Taskinen,et al.  New insights into the pathophysiology of dyslipidemia in type 2 diabetes. , 2015, Atherosclerosis.

[20]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[21]  Christian Gieger,et al.  Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach , 2013, Diabetes.

[22]  W. Wahli,et al.  The peroxisomal enzyme L-PBE is required to prevent the dietary toxicity of medium-chain fatty acids. , 2013, Cell reports.

[23]  R. Vasan,et al.  2-Aminoadipic acid is a biomarker for diabetes risk. , 2013, The Journal of clinical investigation.

[24]  M. Prentki,et al.  Metabolic signaling in fuel-induced insulin secretion. , 2013, Cell metabolism.

[25]  R. Ringseis,et al.  Carnitine supplementation to obese Zucker rats prevents obesity-induced type II to type I muscle fiber transition and favors an oxidative phenotype of skeletal muscle , 2013, Nutrition & Metabolism.

[26]  Gabi Kastenmüller,et al.  Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance , 2013, Diabetes.

[27]  F. Schütz,et al.  Hepatic glucose sensing is required to preserve β cell glucose competence. , 2013, The Journal of clinical investigation.

[28]  A. Wagers,et al.  Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states. , 2013, Cell reports.

[29]  Christian Gieger,et al.  Novel biomarkers for pre-diabetes identified by metabolomics , 2012, Molecular systems biology.

[30]  F. Hu,et al.  Integrating genetic association, genetics of gene expression, and single nucleotide polymorphism set analysis to identify susceptibility Loci for type 2 diabetes mellitus. , 2012, American journal of epidemiology.

[31]  P. Somerharju,et al.  Phosphatidylinositol Transfer Protein, Cytoplasmic 1 (PITPNC1) Binds and Transfers Phosphatidic Acid* , 2012, The Journal of Biological Chemistry.

[32]  T. Lehtimäki,et al.  Circulating Metabolite Predictors of Glycemia in Middle-Aged Men and Women , 2012, Diabetes Care.

[33]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[34]  P. Meikle,et al.  Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction , 2012, Islets.

[35]  R. Scharfmann,et al.  A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion. , 2011, The Journal of clinical investigation.

[36]  B. Thorens,et al.  Oxidative Phosphorylation Flexibility in the Liver of Mice Resistant to High-Fat Diet–Induced Hepatic Steatosis , 2011, Diabetes.

[37]  M. Prentki,et al.  Type 2 diabetes across generations: from pathophysiology to prevention and management , 2011, The Lancet.

[38]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[39]  Matej Oresic,et al.  Peroxisomal and Microsomal Lipid Pathways Associated with Resistance to Hepatic Steatosis and Reduced Pro-inflammatory State* , 2010, The Journal of Biological Chemistry.

[40]  F. Galvano,et al.  l-Carnitine Supplementation to Diet: A New Tool in Treatment of Nonalcoholic Steatohepatitis—A Randomized and Controlled Clinical Trial , 2010, The American Journal of Gastroenterology.

[41]  Pascal G. P. Martin,et al.  The key roles of elongases and desaturases in mammalian fatty acid metabolism: Insights from transgenic mice. , 2010, Progress in lipid research.

[42]  Bernard Thorens,et al.  Glucagon-like Peptide-1 Increases β-Cell Glucose Competence and Proliferation by Translational Induction of Insulin-like Growth Factor-1 Receptor Expression* , 2010, The Journal of Biological Chemistry.

[43]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[44]  A. von Eckardstein,et al.  Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. , 2009, Endocrinology.

[45]  A. Tengholm,et al.  Oscillatory control of insulin secretion , 2009, Molecular and Cellular Endocrinology.

[46]  Steve Horvath,et al.  WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.

[47]  T. Asano,et al.  Regulation of Pancreatic β Cell Mass by Neuronal Signals from the Liver , 2008, Science.

[48]  Eric E Schadt,et al.  Cycle Regulation in Islets with Diabetes Susceptibility a Gene Expression Network Model of Type 2 Diabetes Links Cell P

, 2008 .

[49]  J. Girard,et al.  Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. , 2008, The Journal of clinical investigation.

[50]  R. Mirmira.  Faculty Opinions recommendation of Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. , 2007 .

[51]  M. Prentki,et al.  Islet beta cell failure in type 2 diabetes. , 2006, The Journal of clinical investigation.

[52]  M. Taskinen,et al.  Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes , 2005, Diabetologia.

[53]  M. Mcdaniel,et al.  Pancreatic β-Cell Lipoprotein Lipase Independently Regulates Islet Glucose Metabolism and Normal Insulin Secretion* , 2005, Journal of Biological Chemistry.

[54]  M. White.  Insulin Signaling in Health and Disease , 2003, Science.

[55]  J. Lang.  PIPs and pools in insulin secretion , 2003, Trends in Endocrinology & Metabolism.

[56]  M. Mcdaniel,et al.  Relative Hypoglycemia and Hyperinsulinemia in Mice with Heterozygous Lipoprotein Lipase (LPL) Deficiency , 1999, The Journal of Biological Chemistry.

[57]  B. Glaser,et al.  Pancreatic beta-cell glucokinase: closing the gap between theoretical concepts and experimental realities. , 1998, Diabetes.

[58]  D. Pipeleers,et al.  Prolonged exposure of human beta cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. , 1996, The Journal of clinical investigation.

[59]  J. McGarry,et al.  Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. , 1996, The Journal of clinical investigation.

[60]  J. H. Johnson,et al.  Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Yun-ping Zhou,et al.  Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. , 1994, The Journal of clinical investigation.

[62]  V. Grill,et al.  A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and B cell oxidation through a process likely coupled to fatty acid oxidation. , 1990, Endocrinology.

[63]  Y. Benjamini,et al.  More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.

[64]  J. Miyazaki,et al.  Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. , 1990, Endocrinology.

[65]  A. B. Robinson,et al.  Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[67]  Min Zhang,et al.  Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes. , 2006, Nature genetics.

[68]  J. Fruchart,et al.  Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. , 2006, Drugs of today.

[69]  R. Kulkarni.  New insights into the roles of insulin/IGF-I in the development and maintenance of beta-cell mass. , 2005, Reviews in endocrine & metabolic disorders.